New report shows better diabetes management saves money and improves patient outcomes

A recent IHS Markit report, “The Clinical and Economic Benefits of Better Treatment of Adult Medicaid Beneficiaries with Diabetes,” simulated savings in the Medicaid program as a result of better...
Read More
Protect your health: Important disaster preparedness tips for Harvey and Irma

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
10 years of living and managing type 1 diabetes; lessons learned

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday: Progress in fight against diabetes is one more thing to be thankful for this year

30 million. 1.4 million. 11 million. 86 million. These numbers on their own may mean nothing, but in the context of diabetes, they paint an entirely different picture. More than 30 million...
Read More
Reflecting on terrific progress in treating diabetes

There is no doubt that diabetes is a complex disease to diagnose and treat. That’s something I’ve seen firsthand as an endocrinologist. Over the years, I treated a number of patients that had a...
Read More
New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives

Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the...
Read More
Burden on patients: Insurance benefit design’s impact on patient access to medicines

Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents...
Read More
New report celebrates a decade of progress in chronic diseases

In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...
Read More
Patients and researchers say “we’re fighting back” in new “From Hope to Cures” ads

Diagnosed with type 1 diabetes at a young age, five-year-old Rhys has not let his diagnosis be his destiny. He enjoys life to the fullest, from playing sports to having treats at a friend’s...
Read More
Ask About Adherence: Q&A with Dr. Helaine Resnick on diabetes care

Ask About Adherence is a blog series featuring Q&A’s with experts in medication adherence. In this post, we speak with Helaine E. Resnick, PhD, MPH about her recently published literature review...
Read More